Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity

Biomerica

15/10/2025 14:36

Overview

Biomerica fiscal Q1 revenue fell to $1.4 mln from $1.8 mln, reflecting reduced retail activity

Gross margin improved to 31% from 16%, driven by higher-margin product mix

Operating expenses decreased to $1.5 mln, highlighting cost discipline

Outlook

Biomerica did not provide specific financial guidance for future periods

Result Drivers

HIGHER-MARGIN PRODUCT MIX - Improved gross margin driven by contribution from higher-margin products

COST REDUCTION - Decline in operating expenses due to focus on cost reduction and operational efficiency

NON-RECURRING TAX CREDIT - Net profit aided by non-recurring tax credit

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
$1.40 mln
Q1 Net Income
$0.0
Q1 Gross Margin
31%
Q1 Operating Expenses
$1.50 mln
Q1 Operating Income
-$1.10 mln


Press Release: ID:nGNXcc5s9M

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)